Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation
dc.contributor.author | Korantzopoulos, P. | en |
dc.contributor.author | Kolettis, T. M. | en |
dc.contributor.author | Kountouris, E. | en |
dc.contributor.author | Dimitroula, V. | en |
dc.contributor.author | Karanikis, P. | en |
dc.contributor.author | Pappa, E. | en |
dc.contributor.author | Siogas, K. | en |
dc.contributor.author | Goudevenos, J. A. | en |
dc.date.accessioned | 2015-11-24T19:00:44Z | |
dc.date.available | 2015-11-24T19:00:44Z | |
dc.identifier.issn | 0167-5273 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19586 | |
dc.rights | Default Licence | - |
dc.subject | Administration, Oral | en |
dc.subject | Aged | en |
dc.subject | Antioxidants/*administration & dosage | en |
dc.subject | Ascorbic Acid/*administration & dosage | en |
dc.subject | Atrial Fibrillation/epidemiology/physiopathology/*therapy | en |
dc.subject | Biological Markers/blood | en |
dc.subject | C-Reactive Protein/metabolism | en |
dc.subject | Echocardiography | en |
dc.subject | Electric Countershock/*adverse effects | en |
dc.subject | Electrocardiography/drug effects | en |
dc.subject | Female | en |
dc.subject | Ferritins/blood | en |
dc.subject | Fibrinogen/metabolism | en |
dc.subject | Follow-Up Studies | en |
dc.subject | Heart Atria/ultrasonography | en |
dc.subject | Humans | en |
dc.subject | Incidence | en |
dc.subject | Inflammation/blood/drug therapy/etiology | en |
dc.subject | Leukocyte Count | en |
dc.subject | Male | en |
dc.subject | Myocarditis/blood/*drug therapy/etiology | en |
dc.subject | Nephelometry and Turbidimetry | en |
dc.subject | Oxidative Stress/physiology | en |
dc.subject | Prospective Studies | en |
dc.subject | Recurrence/prevention & control | en |
dc.subject | Treatment Outcome | en |
dc.title | Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation | en |
heal.abstract | BACKGROUND: Inflammation and oxidative stress have been recently implicated in the pathophysiology of atrial fibrillation (AF). The aim of this study was to examine the potential benefit of vitamin C on the early recurrence rates and on inflammatory indices after successful cardioversion of persistent AF, as well as to investigate the time course of changes in these indices post-cardioversion. METHODS: We prospectively studied 44 consecutive patients after successful electrical cardioversion of persistent AF. All patients received standard treatment and were randomised in one to one fashion to either oral vitamin C administration or no additional therapy. We followed-up the patients for 7 days performing successive measurements of white blood cell (WBC) count, C-reactive protein (CRP), fibrinogen, and ferritin levels. RESULTS: One week after successful cardioversion, AF recurred in 4.5% of patients in the vitamin C group and in 36.3% of patients in the control group (p=0.024). Compared to baseline values, inflammatory indices decreased after cardioversion in patients receiving vitamin C but did not change significantly in the control group. A significant variance was found in the serial measurements of WBC counts (F=5.86, p=0.001) and of fibrinogen levels (F=4.10, p=0.0084) in the two groups. In the vitamin C group CRP levels were lower on the seventh day (p<0.05). CRP and fibrinogen levels were higher in patients who relapsed into AF compared to patients who maintained sinus rhythm (F=2.77, p=0.044 and F=3.51, p=0.017, respectively). CONCLUSIONS: These findings suggest that vitamin C reduces the early recurrence rates after cardioversion of persistent AF and attenuates the associated low-level inflammation. These effects indicate that therapeutic approaches targeting at inflammation and oxidative stress may exert favourable effects on atrial electrical remodeling. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1016/j.ijcard.2004.12.041 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/15982504 | - |
heal.identifier.secondary | http://ac.els-cdn.com/S0167527305002779/1-s2.0-S0167527305002779-main.pdf?_tid=a7d156dde654f25f2500d9b53b3585f0&acdnat=1333963333_7ace665c0cbaa911eeee237ba9165e66 | - |
heal.journalName | Int J Cardiol | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2005 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: